Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cachet Wenziger

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nephron|February 6, 2022
Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to DialysisJohn Sy, Cachet Wenziger, Maria Marroquin, et al.
Drugs|December 16, 2021
Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19John G Rizk, Cachet Wenziger, Diana Tran, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 6, 2021
Novel Protein to Phosphorous Ratio Score Predicts Mortality in Hemodialysis PatientsDana Bielopolski, Cachet Wenziger, Tali Steinmetz, et al.
Journal of Pain and Symptom Management|April 8, 2021
Changing Institutional Culture Around Hospice Using LEAN Tools to Improve Hospice Utilization in a Veteran PopulationRebecca Liddicoat Yamarik, Cachet Wenziger, Elani Streja, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 19, 2021
Serum Creatinine-to-Cystatin-C Ratio as a Potential Muscle Mass Surrogate and Racial Differences in MortalityJohn G Rizk, Elani Streja, Cachet Wenziger, et al.
Advances in Therapy|January 12, 2024
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US StudyAmita Ketkar, Vincent Willey, Lisa Glasser, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 9, 2020
A faster decline of residual kidney function and erythropoietin stimulating agent hyporesponsiveness in incident hemodialysis patientsHiroshi Kimura, John Sy, Yusuke Okuda, et al.
Current Medical Research and Opinion|July 11, 2023
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US StudyAmita Ketkar, Vincent Willey, Michael Pollack, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2022
Association of serum potassium with decline in residual kidney function in incident hemodialysis patientsYousif Arif, Cachet Wenziger, Jui Ting Hsiung, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nephron|February 6, 2022
Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to DialysisJohn Sy, Cachet Wenziger, Maria Marroquin, et al.
Drugs|December 16, 2021
Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19John G Rizk, Cachet Wenziger, Diana Tran, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 6, 2021
Novel Protein to Phosphorous Ratio Score Predicts Mortality in Hemodialysis PatientsDana Bielopolski, Cachet Wenziger, Tali Steinmetz, et al.
Journal of Pain and Symptom Management|April 8, 2021
Changing Institutional Culture Around Hospice Using LEAN Tools to Improve Hospice Utilization in a Veteran PopulationRebecca Liddicoat Yamarik, Cachet Wenziger, Elani Streja, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 19, 2021
Serum Creatinine-to-Cystatin-C Ratio as a Potential Muscle Mass Surrogate and Racial Differences in MortalityJohn G Rizk, Elani Streja, Cachet Wenziger, et al.
Advances in Therapy|January 12, 2024
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US StudyAmita Ketkar, Vincent Willey, Lisa Glasser, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 9, 2020
A faster decline of residual kidney function and erythropoietin stimulating agent hyporesponsiveness in incident hemodialysis patientsHiroshi Kimura, John Sy, Yusuke Okuda, et al.
Current Medical Research and Opinion|July 11, 2023
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US StudyAmita Ketkar, Vincent Willey, Michael Pollack, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2022
Association of serum potassium with decline in residual kidney function in incident hemodialysis patientsYousif Arif, Cachet Wenziger, Jui Ting Hsiung, et al.
Pageof 2